Advaxis, Inc. Share Price OTC Bulletin Board
Equities
US0076241092
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2022 | 692K 57.7M | Sales 2023 | 13K 1.08M | Capitalization | 7.94M 662M |
---|---|---|---|---|---|
Net income 2022 | -38M -3.17B | Net income 2023 | -48M -4B | EV / Sales 2022 * | - |
Net cash position 2022 | 657K 54.78M | Net Debt 2023 | 3.43M 286M | EV / Sales 2023 | 875 x |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
-0.08
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Ken Berlin
CEO | Chief Executive Officer | 59 | 23/18/23 |
- | - | ||
- | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
CHM | Chairman | 64 | 16/13/16 |
Roni Appel
CEO | Chief Executive Officer | 57 | 01/04/01 |
Murray Goldberg
BRD | Director/Board Member | 79 | 19/23/19 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |